The concept of 'Reproductive Immunity' and its role in the field of IVF is one of the hotly debated and controversial elements of screening and therapy for IVF treatment. Some elements, such as coagulopathy are less controversial and investigated by many practitioners, other areas are reviewed with skepticism by some but investigated with conviction by others. As always in areas of medicine at the cutting edge of scientific validity there is huge variation in practice and no consensus to its value. It is hoped that this - the first survey of its kind - will obtain an understanding of the extent of its use in IVF centers internationally. If the response merits, a follow up survey will be compiled on the approach to treatment and therapies.
This survey, proposed by: Joanne Kwak-Kim, MD, Director, Reproductive Medicine Associate Prof. Dept. of Obstetrics and Gynecology, Associate Prof. Dept. of Microbiology and Immunology, The Chicago Medical School at Rosalind Franklin University of Medicine and Science, and Professor Simon Fishel, Managing Director - Professor of Human Reproduction CARE Fertility Group, UK.